Clever Leaves Granted European Union Good Manufacturing Practices (EU GMP) Certification

Clever Leaves (the “Company”), a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has been granted European Union Good Manufacturing Practices (EU GMP) certification by the Croatian Agency for Medicinal Products and Medical Devices (HALMED) for its pharmaceutical post-harvest facility and laboratory located outside Bogota, Colombia, to produce Active Pharmaceutical […]

Clever Leaves Granted Good Agricultural and Collecting Practices (GACP) Certification

Clever Leaves (the “Company”), a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has been granted Good Agricultural and Collecting Practices (GACP) Certification by the CUMCS (Control Union Medical Cannabis Standard), after meeting the CUMCS’ guidelines for quality and consistency in the cultivation and harvest of medical cannabis. The new […]

Schultze Special Purpose Acquisition Corp. Announces Non-Binding Letter of Intent for a Business Combination with Clever Leaves, a Leading Pharmaceutical-Grade Multi-National Cannabis Operator

RYE BROOK, N.Y. & NEW YORK–(BUSINESS WIRE)–Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“SAMA”) and Clever Leaves International Inc. (“Clever Leaves” or the “Company”) have jointly announced today that they entered into a non-binding letter of intent (the “LOI”) pursuant to which SAMA and Clever Leaves would enter into a business combination, […]

Clever Leaves and Canopy Growth Announce Regional Supply Agreement

 Clever Leaves, a leading multinational operator (MNO) and licensed producer of pharmaceutical-grade cannabis and hemp extracts, and Canopy LATAM Corporation (“Canopy LATAM”), a wholly owned and controlled subsidiary of Canopy Growth Corporation (“Canopy Growth”) (TSX:WEED, NYSE:CGC), announce that both parties have entered into a regional supply agreement. Read More

Clever Leaves Completes First Closing and Raises $14 Million in Series E Financing

Clever Leaves International Inc. (“Clever Leaves” or the “Company”), a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, today announced the first closing of its Series E financing at US$14 million, bringing the Company’s total funding to over US$120 million. Cowen served as exclusive placement agent for the financing […]

How Colombian medical cannabis producers are adapting to the COVID-19 pandemic

Julián Wilches, chief regulatory officer of Clever Leaves, told MJBizDaily that the company is taking measures as recommended by authorities in each of the countries where it operates. The company encourages social distancing and hand-washing throughout all its operations. “Every employee that can work from home is doing so,” Wilches said. Read More

Colombia Allows Medicinal Cannabis for Local Market

The Colombian government issued a new regulation that establishes the regulatory framework to commercialize master cannabis preparations for Colombian medicinal cannabis, a market estimated to comprise some 5 million patients. On March 2, the Ministry of Health issued Resolution 315, which not only opens up the Colombian market for medicinal cannabis but also allows the […]

COVID-19: CLEVER LEAVES’ STATEMENT

At Clever Leaves, the health and well-being of our employees and communities remains our top priority as we continue to monitor the COVID-19 (corona-virus) outbreak. Leveraging the guidance of the CDC and state and local authorities in each of the geographies in which we operate, we have implemented several policies to ensure the health and […]

Will Colombia’s Small Growers Benefit from Commercial Cannabis?

Private firm Clever Leaves, is currently developing its own program to work with growers close to its cultivation site outside of Bogota. “The quality requirements in terms of the flower is tremendously high – you need significant microbiological testing and to avoid issues with metals and pesticide use – and at the same time your […]

Medical Cannabis Exports in Colombia Promise Massive Market Potential

“The reason why it was promoted having an operation in Portugal is because Colombia by regulation does not allow the commercialization of dried flower as a final product. The regulation in Colombia is oriented to the added-value-products and the extraction of final products. Global demand mostly recognizes the flower as a final product. Since there […]